Article Information
History
- December 14, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- David A. Swan1,†,
- Ashish Goyal1,†,
- Chloe Bracis2,†,
- Mia Moore1,
- Elizabeth Krantz1,
- Elizabeth Brown1,3,4,
- Fabian Cardozo-Ojeda1,
- Daniel B Reeves1,
- Fei Gao1,3,
- Peter B. Gilbert1,3,4,
- Lawrence Corey1,3,5,6,7,
- Myron S. Cohen8,
- Holly Janes1,3,4,††,
- Dobromir Dimitrov1,9,†† and
- Joshua T. Schiffer1,5,7,††,*
- 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center; Seattle, WA, USA
- 2Université Grenoble Alpes, TIMC-IMAG / BCM, 38000, Grenoble, France
- 3Public Health Sciences Division, Fred Hutchinson Cancer Research Center; Seattle, WA, USA
- 4Department of Biostatistics, University of Washington, Seattle, WA, USA
- 5Department of Medicine, University of Washington, Seattle, WA, USA
- 6Department of Laboratory Medicine, University of Washington, Seattle, WA, USA
- 7Clinical Research Division, Fred Hutchinson Cancer Research Center; Seattle, WA, USA
- 8Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC USA
- 9Department of Applied Mathematics, University of Washington, Seattle, WA, USA
- ↵*Corresponding author: Joshua T. Schiffer, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N., Seattle, WA 98109-1024, USA, Phone: 206-979-7672, E-mail: jschiffe{at}fredhutch.org
Posted December 14, 2020.
Vaccines that prevent SARS-CoV-2 transmission may prevent or dampen a spring wave of COVID-19 cases and deaths in 2021
